Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses
可切除食管/胃食管连接部癌的新辅助 nivolumab 或 nivolumab 加 LAG-3 抑制剂 relatlimab 治疗:Ib 期试验和 ctDNA 分析
期刊:Nature Medicine
影响因子:58.7
doi:10.1038/s41591-024-02877-z
Ronan J Kelly #, Blair V Landon #, Ali H Zaidi #, Dipika Singh, Jenna V Canzoniero, Archana Balan, Russell K Hales, K Ranh Voong, Richard J Battafarano, Blair A Jobe, Stephen C Yang, Stephen Broderick, Jinny Ha, Kristen A Marrone, Gavin Pereira, Nisha Rao, Aryan Borole, Katerina Karaindrou, Zineb Be